General Information of Drug Off-Target (DOT) (ID: OTWAN10O)

DOT Name Beta-1,3-N-acetylglucosaminyltransferase radical fringe (RFNG)
Synonyms EC 2.4.1.222; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
Gene Name RFNG
UniProt ID
RFNG_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
2.4.1.222
Pfam ID
PF02434
Sequence
MSRARGALCRACLALAAALAALLLLPLPLPRAPAPARTPAPAPRAPPSRPAAPSLRPDDV
FIAVKTTRKNHGPRLRLLLRTWISRARQQTFIFTDGDDPELELQGGDRVINTNCSAVRTR
QALCCKMSVEYDKFIESGRKWFCHVDDDNYVNARSLLHLLSSFSPSQDVYLGRPSLDHPI
EATERVQGGRTVTTVKFWFATGGAGFCLSRGLALKMSPWASLGSFMSTAEQVRLPDDCTV
GYIVEGLLGARLLHSPLFHSHLENLQRLPPDTLLQQVTLSHGGPENPHNVVNVAGGFSLH
QDPTRFKSIHCLLYPDTDWCPRQKQGAPTSR
Function
Glycosyltransferase that initiates the elongation of O-linked fucose residues attached to EGF-like repeats in the extracellular domain of Notch molecules. Modulates NOTCH1 activity by modifying O-fucose residues at specific EGF-like domains resulting in enhancement of NOTCH1 activation by DLL1 and JAG1. May be involved in limb formation and in neurogenesis.
KEGG Pathway
Other types of O-glycan biosynthesis (hsa00514 )
Notch sig.ling pathway (hsa04330 )
Human papillomavirus infection (hsa05165 )
Reactome Pathway
Pre-NOTCH Processing in Golgi (R-HSA-1912420 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Beta-1,3-N-acetylglucosaminyltransferase radical fringe (RFNG). [1]
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of Beta-1,3-N-acetylglucosaminyltransferase radical fringe (RFNG). [4]
------------------------------------------------------------------------------------
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Beta-1,3-N-acetylglucosaminyltransferase radical fringe (RFNG). [2]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Beta-1,3-N-acetylglucosaminyltransferase radical fringe (RFNG). [3]
Quercetin DM3NC4M Approved Quercetin increases the expression of Beta-1,3-N-acetylglucosaminyltransferase radical fringe (RFNG). [5]
Tocopherol DMBIJZ6 Phase 2 Tocopherol increases the expression of Beta-1,3-N-acetylglucosaminyltransferase radical fringe (RFNG). [6]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Beta-1,3-N-acetylglucosaminyltransferase radical fringe (RFNG). [7]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of Beta-1,3-N-acetylglucosaminyltransferase radical fringe (RFNG). [8]
THAPSIGARGIN DMDMQIE Preclinical THAPSIGARGIN increases the expression of Beta-1,3-N-acetylglucosaminyltransferase radical fringe (RFNG). [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

References

1 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
2 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
3 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
4 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
5 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
6 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
7 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
8 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
9 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.